Cargando…

Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes

Recent reports have demonstrated the association between type 1 diabetes mellitus (T1DM) and increased morbidity and mortality rates during coronavirus disease (COVID-19) infection, setting a priority of these patients for vaccination. Impaired innate and adaptive immunity observed in T1DM seem to p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kountouri, Aikaterini, Korakas, Emmanouil, Ikonomidis, Ignatios, Raptis, Athanasios, Tentolouris, Nikolaos, Dimitriadis, George, Lambadiari, Vaia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151267/
https://www.ncbi.nlm.nih.gov/pubmed/34065123
http://dx.doi.org/10.3390/antiox10050752
_version_ 1783698342193135616
author Kountouri, Aikaterini
Korakas, Emmanouil
Ikonomidis, Ignatios
Raptis, Athanasios
Tentolouris, Nikolaos
Dimitriadis, George
Lambadiari, Vaia
author_facet Kountouri, Aikaterini
Korakas, Emmanouil
Ikonomidis, Ignatios
Raptis, Athanasios
Tentolouris, Nikolaos
Dimitriadis, George
Lambadiari, Vaia
author_sort Kountouri, Aikaterini
collection PubMed
description Recent reports have demonstrated the association between type 1 diabetes mellitus (T1DM) and increased morbidity and mortality rates during coronavirus disease (COVID-19) infection, setting a priority of these patients for vaccination. Impaired innate and adaptive immunity observed in T1DM seem to play a major role. Severe, life-threatening COVID-19 disease is characterized by the excessive release of pro-inflammatory cytokines, known as a “cytokine storm”. Patients with T1DM present elevated levels of cytokines including interleukin-1a (IL), IL-1β, IL-2, IL-6 and tumor necrosis factor alpha (TNF-α), suggesting the pre-existence of chronic inflammation, which, in turn, has been considered the major risk factor of adverse COVID-19 outcomes in many cohorts. Even more importantly, oxidative stress is a key player in COVID-19 pathogenesis and determines disease severity. It is well-known that extreme glucose excursions, the prominent feature of T1DM, are a potent mediator of oxidative stress through several pathways including the activation of protein kinase C (PKC) and the increased production of advanced glycation end products (AGEs). Additionally, chronic endothelial dysfunction and the hypercoagulant state observed in T1DM, in combination with the direct damage of endothelial cells by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), may result in endothelial and microcirculation impairment, which contribute to the pathogenesis of acute respiratory syndrome and multi-organ failure. The binding of SARS-CoV-2 to angiotensin converting enzyme 2 (ACE2) receptors in pancreatic b-cells permits the direct destruction of b-cells, which contributes to the development of new-onset diabetes and the induction of diabetic ketoacidosis (DKA) in patients with T1DM. Large clinical studies are required to clarify the exact pathways through which T1DM results in worse COVID-19 outcomes.
format Online
Article
Text
id pubmed-8151267
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81512672021-05-27 Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes Kountouri, Aikaterini Korakas, Emmanouil Ikonomidis, Ignatios Raptis, Athanasios Tentolouris, Nikolaos Dimitriadis, George Lambadiari, Vaia Antioxidants (Basel) Review Recent reports have demonstrated the association between type 1 diabetes mellitus (T1DM) and increased morbidity and mortality rates during coronavirus disease (COVID-19) infection, setting a priority of these patients for vaccination. Impaired innate and adaptive immunity observed in T1DM seem to play a major role. Severe, life-threatening COVID-19 disease is characterized by the excessive release of pro-inflammatory cytokines, known as a “cytokine storm”. Patients with T1DM present elevated levels of cytokines including interleukin-1a (IL), IL-1β, IL-2, IL-6 and tumor necrosis factor alpha (TNF-α), suggesting the pre-existence of chronic inflammation, which, in turn, has been considered the major risk factor of adverse COVID-19 outcomes in many cohorts. Even more importantly, oxidative stress is a key player in COVID-19 pathogenesis and determines disease severity. It is well-known that extreme glucose excursions, the prominent feature of T1DM, are a potent mediator of oxidative stress through several pathways including the activation of protein kinase C (PKC) and the increased production of advanced glycation end products (AGEs). Additionally, chronic endothelial dysfunction and the hypercoagulant state observed in T1DM, in combination with the direct damage of endothelial cells by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), may result in endothelial and microcirculation impairment, which contribute to the pathogenesis of acute respiratory syndrome and multi-organ failure. The binding of SARS-CoV-2 to angiotensin converting enzyme 2 (ACE2) receptors in pancreatic b-cells permits the direct destruction of b-cells, which contributes to the development of new-onset diabetes and the induction of diabetic ketoacidosis (DKA) in patients with T1DM. Large clinical studies are required to clarify the exact pathways through which T1DM results in worse COVID-19 outcomes. MDPI 2021-05-09 /pmc/articles/PMC8151267/ /pubmed/34065123 http://dx.doi.org/10.3390/antiox10050752 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kountouri, Aikaterini
Korakas, Emmanouil
Ikonomidis, Ignatios
Raptis, Athanasios
Tentolouris, Nikolaos
Dimitriadis, George
Lambadiari, Vaia
Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes
title Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes
title_full Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes
title_fullStr Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes
title_full_unstemmed Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes
title_short Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes
title_sort type 1 diabetes mellitus in the sars-cov-2 pandemic: oxidative stress as a major pathophysiological mechanism linked to adverse clinical outcomes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151267/
https://www.ncbi.nlm.nih.gov/pubmed/34065123
http://dx.doi.org/10.3390/antiox10050752
work_keys_str_mv AT kountouriaikaterini type1diabetesmellitusinthesarscov2pandemicoxidativestressasamajorpathophysiologicalmechanismlinkedtoadverseclinicaloutcomes
AT korakasemmanouil type1diabetesmellitusinthesarscov2pandemicoxidativestressasamajorpathophysiologicalmechanismlinkedtoadverseclinicaloutcomes
AT ikonomidisignatios type1diabetesmellitusinthesarscov2pandemicoxidativestressasamajorpathophysiologicalmechanismlinkedtoadverseclinicaloutcomes
AT raptisathanasios type1diabetesmellitusinthesarscov2pandemicoxidativestressasamajorpathophysiologicalmechanismlinkedtoadverseclinicaloutcomes
AT tentolourisnikolaos type1diabetesmellitusinthesarscov2pandemicoxidativestressasamajorpathophysiologicalmechanismlinkedtoadverseclinicaloutcomes
AT dimitriadisgeorge type1diabetesmellitusinthesarscov2pandemicoxidativestressasamajorpathophysiologicalmechanismlinkedtoadverseclinicaloutcomes
AT lambadiarivaia type1diabetesmellitusinthesarscov2pandemicoxidativestressasamajorpathophysiologicalmechanismlinkedtoadverseclinicaloutcomes